Tuagon, Mark Jade P.

HRN: 19-96-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
CEFUROXIME 1.5GM (VIAL)
01/02/2026
01/08/2026
IV
580mg
Q8
AGE, URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: